Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2024
[Application of human-derived samples in preclinical research]Hiroshi Yukitake
Oxidative Medicine and Cellular Longevity|February 14, 2017
Macrophage Migration Inhibitory Factor as an Emerging Drug Target to Regulate Antioxidant Response Element SystemHiroshi Yukitake, Masayuki Takizawa, Haruhide Kimura
Biochemical and Biophysical Research Communications|November 2, 2025
AAV9-mediated NGLY1 gene replacement suppresses non-epileptic convulsions in Ngly1-/- ratsMakoto Asahina, Reiko Fujinawa, Hiroto Hirayama, et al.
Communications Biology|April 22, 2024
Intranasal oxytocin suppresses seizure-like behaviors in a mouse model of NGLY1 deficiencyYukimasa Makita, Makoto Asahina, Reiko Fujinawa, et al.
European Journal of Cell Biology|July 26, 2024
Elimination of the extra chromosome of Dup15q syndrome iPSCs for cellular and molecular investigationHaruka Munezane, Keiko Imamura, Naoko Fujimoto, et al.
The Journal of Biological Chemistry|September 12, 2002
AAT-1, a novel testis-specific AMY-1-binding protein, forms a quaternary complex with AMY-1, A-kinase anchor protein 84, and a regulatory subunit of cAMP-dependent protein kinase and is phosphorylated by its kinaseHiroshi Yukitake, Makoto Furusawa, Takahiro Taira, et al.
Biochimica Et Biophysica Acta|August 2, 2002
AMAP-1, a novel testis-specific AMY-1-binding protein, is differentially expressed during the course of spermatogenesisHiroshi Yukitake, Makoto Furusawa, Takahiro Taira, et al.
European Journal of Pharmacology|January 2, 2013
BTZO-2, an antioxidant response element-activator, provides protection against lethal endotoxic shock in miceHiroshi Yukitake, Haruhide Kimura, Yasukazu Tajima, et al.
Plos One|August 20, 2011
BTZO-15, an ARE-activator, ameliorates DSS- and TNBS-induced colitis in ratsHiroshi Yukitake, Haruhide Kimura, Hirobumi Suzuki, et al.
Journal of Pharmacological Sciences|June 23, 2009
The chondroprotective agent ITZ-1 inhibits interleukin-1beta-induced matrix metalloproteinase-13 production and suppresses nitric oxide-induced chondrocyte deathHaruhide Kimura, Hiroshi Yukitake, Hirobumi Suzuki, et al.
Pageof 2